# Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE

> **NCT05907902** · PHASE3 · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 824 (estimated)

## Conditions studied

- Intracranial Aneurysm
- Cerebrovascular Disease

## Interventions

- **DRUG:** Aspirin Enteric-coated Tablets

## Key facts

- **NCT ID:** NCT05907902
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-01
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-07-01
- **Target enrollment:** 824 (ESTIMATED)
- **Last updated:** 2023-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05907902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05907902, "Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05907902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*